Table of Contents
ISRN Veterinary Science
Volume 2012 (2012), Article ID 951306, 3 pages
http://dx.doi.org/10.5402/2012/951306
Research Article

Plasma Disposition of Conventional and Long-Acting Moxifloxacin in Sheep after Intravenous Administration

Department of Pharmacology and Toxicology, College of Veterinary Science and Animal Husbandry, Sardarkrushinagar Dantiwada Agricultural University, Sardarkrushinagar, North Gujarat, Dantiwada 385 506, India

Received 24 May 2012; Accepted 26 July 2012

Academic Editors: H. J. Klein, J. E. Uzonna, and J. K. Yamamoto

Copyright © 2012 C. M. Modi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Spreng, J. Deleforge, V. Thomas, B. Boisrame, and H. Drugeon, “Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolates,” Journal of Veterinary Pharmacology and Therapeutics, vol. 18, no. 4, pp. 284–289, 1995. View at Google Scholar · View at Scopus
  2. S. A. Brown, “Fluoroquinolones in animal health,” Journal of Veterinary Pharmacology and Therapeutics, vol. 19, no. 1, pp. 1–14, 1996. View at Google Scholar · View at Scopus
  3. B. Ji, S. Lefrançois, J. Robert, A. Chauffour, C. Truffot, and V. Jarlier, “In vitro and in vivo activities of rifampin, streptomycin, amikacin, moxifloxacin, R207910, linezolid, and PA-824 against Mycobacterium ulcerans,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 6, pp. 1921–1926, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Fernández-Varón, M. J. Bovaira, A. Espuny, E. Escudero, D. Vancraeynest, and C. M. Cárceles, “Pharmacokinetic-pharmacodynamic integration of moxifloxacin in rabbits after intravenous, intramuscular and oral administration,” Journal of Veterinary Pharmacology and Therapeutics, vol. 28, no. 4, pp. 343–348, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. R. P. Kowalski, D. K. Dhaliwal, L. M. Karenchak et al., “Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates,” American Journal of Ophthalmology, vol. 136, no. 3, pp. 500–505, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. H. M. Siefert, A. Domdey-Bette, K. Henninger, F. Hucke, C. Kohlsdorfer, and H. H. Stass, “Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: a comparison in humans and other mammalian species,” Journal of Antimicrobial Chemotherapy, vol. 43, pp. 69–76, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. J. M. Woodcock, J. M. Andrews, F. J. Boswell, N. P. Brenwald, and R. Wise, “In vitro activity of BAY 12-8039, a new fluoroquinolone,” Antimicrobial Agents and Chemotherapy, vol. 41, no. 1, pp. 101–106, 1997. View at Google Scholar · View at Scopus